Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparability of Controlled Allergen Challenge Facilities
NCT02543346Phase 4Completed
- Sponsor
- Queen's University
- Start
- Oct 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in Seasonal Allergic Rhinoconjunctivitis (SAR) comparing Cetirizine with Placebo (2 arms). Primary endpoint: Total Rhinoconjunctivitis Symptom Score. Started Oct 2015; status: completed.
02
Drugs
cetirizine
03
Conditions
Seasonal Allergic Rhinoconjunctivitis (SAR)
Beyond the preview
Go deeper on NCT02543346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543346.